Riluzole: real-world evidence supports significant extension of median survival times in patients with amyotrophic lateral sclerosis

Overview of attention for article published in Degenerative Neurological and Neuromuscular Disease, May 2017

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 1 public wall post.

Riluzole: the only drug that could extend amyotrophic lateral sclerosis survival times by up to 19 months? #ALS http://ow.ly/guVf…

This page shows the most recent Facebook posts that mention this research output.

Click here to find out how to access more activity.